In the world of tech, computational chemistry is a hot ticket.
And Molecule.one leads the pack.
When creating ground-breaking drugs, hopes hang on molecules that don’t yet exist.
While simulations are great, science needs more substance, less theory.
How do you make hypothetical molecules?
Or enough for real world testing?
They’ve created a software platform that automates the process.
The secret is machine learning. Absorbing millions of patents and processes, the software connects the dots. Then it creates a method for making it.
All drug companies must do is to identify what they need a drug to do.
Molecule.one masters the how.
The platform will debut onstage at the Disrupt SF Startup Battlefield.
“Our system works for structures that have never been seen before by any chemist.”
Read more here.